Literature DB >> 16857578

Adiposity indices and dementia.

Deborah Gustafson1.   

Abstract

Indicators of adiposity, such as body-mass index (BMI), may be markers for changes in energy metabolism that influence dementia risk, progression, and ultimately death. Cross-sectional studies show that people with dementia have a lower BMI than those without dementia, which is potentially due to a greater rate of BMI decline occurring during the years immediately preceding dementia onset. However, a high BMI can also increase the risk for dementia when measured before clinical dementia onset, which might be due to vascular disorders or bioactive hormonal compounds that are secreted by adipose tissue. In this personal view, I consider how dementia is associated with BMI by looking at the role of BMI and obesity syndromes, mechanisms associated with adiposity, and the potential for hypothalamic dysregulation during the life course. Understanding the life course of adiposity by use of common surrogate measures, such as BMI, among those who do and do not develop dementia is relevant for understanding the causes of dementia and for shaping possible treatment options.

Entities:  

Mesh:

Year:  2006        PMID: 16857578     DOI: 10.1016/S1474-4422(06)70526-9

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN: 1474-4422            Impact factor:   44.182


  74 in total

1.  The importance of cognitive aging for understanding dementia.

Authors:  Archana Singh-Manoux; Mika Kivimäki
Journal:  Age (Dordr)       Date:  2010-05-08

2.  Aging-related gene expression in hippocampus proper compared with dentate gyrus is selectively associated with metabolic syndrome variables in rhesus monkeys.

Authors:  Eric M Blalock; Richard Grondin; Kuey-chu Chen; Olivier Thibault; Veronique Thibault; Jignesh D Pandya; Amy Dowling; Zhiming Zhang; Patrick Sullivan; Nada M Porter; Philip W Landfield
Journal:  J Neurosci       Date:  2010-04-28       Impact factor: 6.167

3.  Overweight in midlife is related to lower cognitive function 30 years later: a prospective study with longitudinal assessments.

Authors:  Linda B Hassing; Anna K Dahl; Nancy L Pedersen; Boo Johansson
Journal:  Dement Geriatr Cogn Disord       Date:  2010-07-03       Impact factor: 2.959

Review 4.  Central nervous system involvement in diabetes mellitus.

Authors:  Dinesh Selvarajah; Solomon Tesfaye
Journal:  Curr Diab Rep       Date:  2006-12       Impact factor: 4.810

5.  Microarray analyses of laser-captured hippocampus reveal distinct gray and white matter signatures associated with incipient Alzheimer's disease.

Authors:  Eric M Blalock; Heather M Buechel; Jelena Popovic; James W Geddes; Philip W Landfield
Journal:  J Chem Neuroanat       Date:  2011-07-02       Impact factor: 3.052

6.  Predictors of cognitive impairment and dementia in older people with diabetes.

Authors:  D G Bruce; W A Davis; G P Casey; S E Starkstein; R M Clarnette; J K Foster; O P Almeida; T M E Davis
Journal:  Diabetologia       Date:  2007-12-05       Impact factor: 10.122

7.  Body mass index over the adult life course and cognition in late midlife: the Whitehall II Cohort Study.

Authors:  Séverine Sabia; Mika Kivimaki; Martin J Shipley; Michael G Marmot; Archana Singh-Manoux
Journal:  Am J Clin Nutr       Date:  2008-12-10       Impact factor: 7.045

Review 8.  Obesity as a risk factor for Alzheimer's disease: the role of adipocytokines.

Authors:  Liliana Letra; Isabel Santana; Raquel Seiça
Journal:  Metab Brain Dis       Date:  2014-02-20       Impact factor: 3.584

9.  Amyloid-beta burden predicts prospective decline in body mass index in clinically normal adults.

Authors:  Jennifer S Rabin; Zahra Shirzadi; Walter Swardfager; Bradley J MacIntosh; Aaron Schultz; Hyun-Sik Yang; Rachel F Buckley; Jennifer R Gatchel; Dylan Kirn; Jeremy J Pruzin; Trey Hedden; Nir Lipsman; Dorene M Rentz; Sandra E Black; Keith A Johnson; Reisa A Sperling; Jasmeer P Chhatwal
Journal:  Neurobiol Aging       Date:  2020-03-07       Impact factor: 4.673

10.  Adiposity indicators and dementia over 32 years in Sweden.

Authors:  D R Gustafson; K Bäckman; M Waern; S Ostling; X Guo; P Zandi; M M Mielke; C Bengtsson; I Skoog
Journal:  Neurology       Date:  2009-11-10       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.